Annual Total Debt
$68.23 M
+$42.29 M+163.07%
December 31, 2023
Summary
- As of February 22, 2025, TRDA annual total debt is $68.23 million, with the most recent change of +$42.29 million (+163.07%) on December 31, 2023.
- During the last 3 years, TRDA annual total debt has risen by +$68.23 million (+100.00%).
- TRDA annual total debt is now at all-time high.
Performance
TRDA Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$61.31 M
-$3.13 M-4.86%
September 30, 2024
Summary
- As of February 22, 2025, TRDA quarterly total debt is $61.31 million, with the most recent change of -$3.13 million (-4.86%) on September 30, 2024.
- Over the past year, TRDA quarterly total debt has dropped by -$7.76 million (-11.23%).
- TRDA quarterly total debt is now -16.05% below its all-time high of $73.03 million, reached on June 30, 2023.
Performance
TRDA Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
TRDA Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +163.1% | -11.2% |
| 3 y3 years | +100.0% | +136.4% |
| 5 y5 years | +100.0% | +136.4% |
TRDA Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -16.1% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -16.1% | -100.0% |
| alltime | all time | at high | -100.0% | -16.1% | -100.0% |
Entrada Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $61.31 M(-4.9%) |
| Jun 2024 | - | $64.44 M(-3.0%) |
| Mar 2024 | - | $66.43 M(-2.6%) |
| Dec 2023 | $68.23 M(+163.1%) | $68.23 M(-1.2%) |
| Sep 2023 | - | $69.07 M(-5.4%) |
| Jun 2023 | - | $73.03 M(+350.1%) |
| Mar 2023 | - | $16.23 M(-37.4%) |
| Dec 2022 | $25.94 M | $25.94 M(-7.2%) |
| Sep 2022 | - | $27.95 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $29.91 M(-6.1%) |
| Mar 2022 | - | $31.86 M(>+9900.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00 |
| Dec 2019 | $0.00 | - |
FAQ
- What is Entrada Therapeutics annual total debt?
- What is the all time high annual total debt for Entrada Therapeutics?
- What is Entrada Therapeutics annual total debt year-on-year change?
- What is Entrada Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly total debt year-on-year change?
What is Entrada Therapeutics annual total debt?
The current annual total debt of TRDA is $68.23 M
What is the all time high annual total debt for Entrada Therapeutics?
Entrada Therapeutics all-time high annual total debt is $68.23 M
What is Entrada Therapeutics annual total debt year-on-year change?
Over the past year, TRDA annual total debt has changed by +$42.29 M (+163.07%)
What is Entrada Therapeutics quarterly total debt?
The current quarterly total debt of TRDA is $61.31 M
What is the all time high quarterly total debt for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly total debt is $73.03 M
What is Entrada Therapeutics quarterly total debt year-on-year change?
Over the past year, TRDA quarterly total debt has changed by -$7.76 M (-11.23%)